EQT Reportedly Nearing QIAGEN Offer at €46.50 a Share
Bloomberg reports QIAGEN’s supervisory board may soon back EQT’s proposed bid, though no final decision has been made.
Makkler Newsroom · Oct 22, 06:37 AM · 1 min read
Market closed· · AUD · Data may be delayed
Avg. target AUD 23.43 (+11.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.